1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Stomach Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duris, I; Kinova, S; Kovacova, E; Remkova, A | 1 |
Ishii, S; Izumi, T; Kato, S; Mutoh, H; Shimizu, T | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Stomach Neoplasms
Article | Year |
---|---|
General changes in hemostasis in gastric cancer.
Topics: Adult; Aged; Blood Coagulation Factor Inhibitors; Female; Fibrinolysis; Hemostasis; Humans; Male; Middle Aged; Paraneoplastic Syndromes; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Count; Prothrombin Time; Stomach Neoplasms | 2009 |
Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B.
Topics: Base Sequence; Cell Line; Chloramphenicol O-Acetyltransferase; DNA Primers; Gene Expression Regulation, Neoplastic; Humans; Leukocytes; Molecular Sequence Data; NF-kappa B; Open Reading Frames; Platelet Activating Factor; Platelet Membrane Glycoproteins; Promoter Regions, Genetic; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Stomach Neoplasms; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Up-Regulation | 1994 |